Safety and Efficacy Study of Parkinson's Disease Gene Therapy Drug (BBM-P002)
Clinical trial NCT05822739 · COMPLETED
Trial details
- NCT number
- NCT05822739
- Sponsor
- Xiangya Hospital of Central South University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-14
- Primary completion
- 2025-10-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.